February 5, 2010 — Results from 8 clinical trials show that recombinant human thrombin (rThrombin; Recothrom, ZymoGenetics, Inc) is well tolerated in several surgical settings for topical hemostasis ...

United Health Products, Inc. (OTCQB: UEEC) today provided a status update on its discussions with the Food & Drug ...

The leading cause of death due to injuries in war is excessive bleeding. A KAIST research team, in which an Army Major participated, has tackled this issue head-on. By developing a next-generation ...

Routine use of expensive hemostatic agents during RALPN does not seem to be justified. The use of hemostatic agents (HAs) during standard robotic-assisted laparoscopic partial nephrectomy (RALPN) does ...

The global Biosurgery Market is expected to expand at a compound annual growth rate (CAGR) of approximately 5% between 2025 ...

Uncontrolled bleeding during surgery remains one of the deadliest medical emergencies. Injuries to internal organs such as the liver or spleen are especially dangerous because bleeding is difficult to ...